Review paper
Mesenchymal stem cells to treat liver diseases
Abstract
: Mesenchymal stem cells (MSCs) are being developed for stem cell therapy and can be efficiently used in regenerative medicine. To date, more than 1,000 clinical trials have used MSCs; of these, more than 80 clinical trials have targeted liver disease. MSCs migrate to damaged liver tissues, differentiate into hepatocytes, reduce liver inflammatory responses, reduce liver fibrosis, and act as antioxidants. According to the reported literature,...
Paper Details
Title
Mesenchymal stem cells to treat liver diseases
Published Date
Apr 1, 2020
Volume
8
Issue
8
Pages
563 - 563